|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
15,080,000 |
Market
Cap: |
21.56(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.42 - $2.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
24,474 |
Total Buy Value |
$0 |
$0 |
$0 |
$57,060 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
400 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Jones James |
|
|
2023-11-29 |
4 |
A |
$1.73 |
$55 |
D/D |
32 |
31,171 |
|
- |
|
Young Caroline |
|
|
2023-11-29 |
4 |
A |
$1.73 |
$55 |
D/D |
32 |
24,465 |
|
- |
|
Krogulski Kenneth |
|
|
2023-11-29 |
4/A |
A |
$1.73 |
$285 |
D/D |
165 |
229,546 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-11-28 |
4 |
A |
$1.68 |
$42 |
D/D |
25 |
5,719,999 |
|
- |
|
Jones James |
|
|
2023-11-28 |
4 |
A |
$1.68 |
$42 |
D/D |
25 |
31,139 |
|
- |
|
Young Caroline |
|
|
2023-11-28 |
4 |
A |
$1.68 |
$42 |
D/D |
25 |
24,433 |
|
- |
|
Krogulski Kenneth |
|
|
2023-11-28 |
4/A |
A |
$1.68 |
$208 |
D/D |
124 |
229,381 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-11-27 |
4 |
A |
$1.86 |
$134 |
D/D |
72 |
5,719,974 |
|
- |
|
Jones James |
|
|
2023-11-27 |
4 |
A |
$1.86 |
$134 |
D/D |
72 |
31,114 |
|
- |
|
Hamm John M. |
Chief Financial Officer |
|
2023-11-27 |
4 |
D |
$1.67 |
$588 |
D/D |
(352) |
26,448 |
|
- |
|
Young Caroline |
|
|
2023-11-27 |
4 |
A |
$1.86 |
$134 |
D/D |
72 |
24,408 |
|
- |
|
Krogulski Kenneth |
|
|
2023-11-27 |
4/A |
A |
$1.86 |
$705 |
D/D |
379 |
229,257 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-11-22 |
4 |
A |
$1.74 |
$96 |
D/D |
55 |
5,719,902 |
|
- |
|
Jones James |
|
|
2023-11-22 |
4 |
A |
$1.74 |
$96 |
D/D |
55 |
31,042 |
|
- |
|
Young Caroline |
|
|
2023-11-22 |
4 |
A |
$1.74 |
$96 |
D/D |
55 |
24,336 |
|
- |
|
Krogulski Kenneth |
|
|
2023-11-22 |
4/A |
A |
$1.74 |
$487 |
D/D |
280 |
228,878 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-11-21 |
4 |
A |
$1.76 |
$44 |
D/D |
25 |
5,719,847 |
|
- |
|
Jones James |
|
|
2023-11-21 |
4 |
A |
$1.76 |
$44 |
D/D |
25 |
30,987 |
|
- |
|
Young Caroline |
|
|
2023-11-21 |
4 |
A |
$1.76 |
$44 |
D/D |
25 |
24,281 |
|
- |
|
Krogulski Kenneth |
|
|
2023-11-21 |
4/A |
A |
$1.76 |
$220 |
D/D |
125 |
228,598 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-11-20 |
4 |
A |
$1.70 |
$90 |
D/D |
53 |
5,719,822 |
|
- |
|
Jones James |
|
|
2023-11-20 |
4 |
A |
$1.70 |
$90 |
D/D |
53 |
30,962 |
|
- |
|
Young Caroline |
|
|
2023-11-20 |
4 |
A |
$1.70 |
$90 |
D/D |
53 |
24,256 |
|
- |
|
Krogulski Kenneth |
|
|
2023-11-20 |
4/A |
A |
$1.70 |
$456 |
D/D |
268 |
228,473 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-11-17 |
4 |
A |
$1.83 |
$101 |
D/D |
55 |
5,719,769 |
|
- |
|
2465 Records found
|
|
Page 4 of 99 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|